Vinci S.A. (VCISY)
OTC PINK OTC PINK Primary 
Intuitive Surgical Stock Hits Record High on da Vinci Device Demand
Shares of Intuitive Surgical (ISRG) hit an all-time high Friday, a day after the medical device maker posted better-than-expected results on more use of its da Vinci minimally invasive surgical devices.
Intuitive Surgical Q3: Da Vinci 5 Robot Set For 2025, But Overvalued
I reiterate a 'Sell' rating on Intuitive Surgical with a fair value of $350 per share due to its hefty valuation. The Da Vinci 5 robot rollout in mid-2025 is a major catalyst, with significant growth potential from innovative technology and positive surgeon feedback. Despite strong leadership and market position, ISRG's overvaluation and high WACC of 13% justify the 'Sell' rating.
Half Year 2024 Vinci SA Analsyt Meeting Transcript
Half Year 2024 Vinci SA Analsyt Meeting Transcript {"@context":"Click Here News","item":"Click Here
Are Investors Undervaluing Vinci (VCISY) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
